Symphogen AS - Strategic SWOT Analysis Review

Symphogen AS - Strategic SWOT Analysis Review

  • Products Id :- GDPH14584SA
  • |
  • Pages: 25
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Symphogen AS Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.

This up to the minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.


Business description A detailed description of the company's operations and business divisions.

Corporate strategy GlobalData's summarization of the company's business strategy.

SWOT analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history Progression of key events associated with the company.

Major products and services A list of major products, services and brands of the company.

Key competitors A list of key competitors to the company.

Key employees A list of the key executives of the company.

Executive biographies A brief summary of the executives' employment history.

Key operational heads A list of personnel heading key departments/functions.

Important locations and subsidiaries A list of key locations and subsidiaries of the company, including contact details.

Key manufacturing facilities A list of key manufacturing facilities of the company.


Symphogen A/S (Symphogen) is a biopharmaceutical company that specializes in the field of recombinant antibody mixtures for therapeutic use in cancer. The company focuses on developing superior monoclonal antibody (mAb) mixture therapeutics. Its product pipeline provides novel approaches to a wide range of cancer types including metastatic colorectal cancer (mCRC), glioblastoma (GBM), solid tumor malignancies and MET amplified solid tumors and partner targets. It has collaborations for the development of antibody therapeutics in immuno oncology with Shire and infectious disease area with Genentech. The company has offices in Denmark and New Jersey, the US. Symphogen is headquartered in Ballerup, Denmark.

Symphogen AS Key Recent Developments

May 30,2018: Symphogen Further Strengthens its Immuno Oncology Pipeline by Advancing into Two Additional Clinical Trials

Reasons to Buy

Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.

Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services and business strategy.

Understand and respond to your competitors' business structure and strategies with GlobalData's detailed SWOT analysis. In this, the company's core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.

Examine potential investment and acquisition targets with this report's detailed insight into the company's strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1 About the Company 5

Symphogen A/S Key Facts 5

Symphogen A/S Key Employees 6

Symphogen A/S Key Employee Biographies 7

Symphogen A/S Major Products and Services 8

Symphogen A/S History 9

Symphogen A/S Company Statement 11

Symphogen A/S Locations And Subsidiaries 12

Head Office 12

Other Locations & Subsidiaries 12

Section 2 Company Analysis 13

Company Overview 13

Symphogen A/S Business Description 14

Symphogen A/S Corporate Strategy 15

Symphogen A/S SWOT Analysis 16

SWOT Analysis Overview 16

Symphogen A/S Strengths 16

Symphogen A/S Weaknesses 17

Symphogen A/S Opportunities 18

Symphogen A/S Threats 19

Symphogen A/S Key Competitors 20

Section 3 Company's Lifesciences Financial Deals and Alliances 21

Symphogen A/S, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 21

Symphogen A/S, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 22

Symphogen A/S, Recent Deals Summary 23

Section 4 Company's Recent Developments 24

May 30, 2018: Symphogen Further Strengthens its Immuno Oncology Pipeline by Advancing into Two Additional Clinical Trials 24

Section 5 Appendix 25

Methodology 25

About GlobalData 25

Contact Us 25

Disclaimer 25

List of Figures

Symphogen A/S, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 21

Symphogen A/S, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 22

List of Tables

Symphogen A/S, Key Facts 5

Symphogen A/S, Key Employees 6

Symphogen A/S, Key Employee Biographies 7

Symphogen A/S, Major Products and Services 8

Symphogen A/S, History 9

Symphogen A/S, Subsidiaries 12

Symphogen A/S, Key Competitors 20

Symphogen A/S, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 21

Symphogen A/S, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 22

Symphogen A/S, Recent Deals Summary 23

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@]

Zealand Pharma AS

Roche Innovation Center Copenhagen A/S

Nuevolution A/S

Mundipharma A/S

MedAnnex Ltd

Lead Pharma Holding BV

CytoVac AS

Bifodan A/S

Bavarian Nordic A/S

Affitech A/S

2cureX ApS

Symphogen AS, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Overview, Key Manufacturing Facilities, Key Information, Overview, Business Description, Major Products and Services, Brands, History, Key Employees, Key Employee Biographies, Key Operational Heads, Locations And Subsidiaries, Competitors, Company Statement.

select a license
Single User License
USD 125 INR 8750
Site License
USD 250 INR 17500
Corporate User License
USD 375 INR 26250



The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

sales [@]